Updated:
Fujita Innovation Capital
Fujita Innovation Capital is a venture capital firm founded in 2019 in Toyoake, Japan. The firm has made 8 investments, including a Series B - II investment...
Overview
Fujita Innovation Capital is a venture capital firm founded in 2019 in Toyoake, Japan. The firm has made 8 investments, including a Series B - II investment in Metagen Therapeutics on February 25, 2026. Fujita Innovation Capital has 2 portfolio exits, with J-Pharma exiting on March 25, 2026.
General information
Firm type
Private Equity
Year founded
2019
Location
Region
Asia
Country
Japan
City
Toyoake-shi
Corporate office
Toyoake-shi, Aichi, Japan
Sector focus
Frequently asked questions
How does Fujita Innovation Capital source its deal flow?
The firm's primary sourcing advantage is geographic: its Toyoake-shi base places it inside the Chukyo industrial zone, home to Toyota, Denso, Aisin, and hundreds of Tier-1 and Tier-2 suppliers. This physical proximity creates an informal pipeline of spin-outs from corporate R&D labs and university engineering departments that rarely reach Tokyo-based venture funds until later rounds.
Which sectors does Fujita Innovation Capital invest in?
The firm targets deep-tech and industrial sectors tied to Japan's manufacturing economy: industrial automation, robotics, mobility and transportation, enterprise software, and AI/ML applications for the factory floor and supply chain. These sectors map directly onto the expertise base and corporate demand within the greater Nagoya region.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: